Donaco International Ltd Strong performance expected in June half FY17
Strong performance expected in June half FY17: Donaco International Ltd (ASX: DNA) had earlier reported about successful integration of DNA Star Vegas in Poipet in FY 16. The acquisition resulted in a seven-fold increase in the group revenues in FY16. Particularly, DNA reported the group revenue of A$143.4 million in FY 16 up from A$20.4 million, that includes revenue from Star Vegas of A$120.1 million and the Aristo’s revenue of A$23.2 million, which has grown 36% as compared to FY 15. The group had lately announced that first four months of FY17 witnessed a solid VIP win rate of 2.87% for DNA Star Vegas although this was lower than 3.3% win rate of corresponding period in FY16. Overall, the current financial year till October has seen mixed results with strong start from Aristo but lower than expected results from DNA Star Vegas.